Inhibition of spleen tyrosine kinase signaling protects against acute lung injury through blockade of NADPH oxidase and IL-17A in neutrophils and γδ T cells respectively in mice-Reference-Cited by-同舟云学术

Inhibition of spleen tyrosine kinase signaling protects against acute lung injury through blockade of NADPH oxidase and IL-17A in neutrophils and γδ T cells respectively in mice

Published:2019-03 Issue: Volume:68 Page:39-47
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Nadeem Ahmed,Ahmad Sheikh F.,Al-Harbi Naif O.,Al-Harbi Mohammed M.,Ibrahim Khalid E.,Kundu Swati,Attia Sabry M.,Alanazi Wael A.,AlSharari Shakir D.

Funder

King Saud University

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference54 articles.

1. Biomarkers in acute lung injury–marking forward progress;Barnett;Crit. Care Clin.,2011

2. Pathophysiological approaches of acute respiratory distress syndrome: novel bases for study of lung injury;Castillo;Open Respir. Med. J.,2015

3. Emerging drugs for acute lung injury;Impellizzeri;Expert Opin. Emerg. Drugs,2015

4. Fifty years of research in ARDS. The epidemiology of ARDS: a fiftieth birthday review;Ti;Am. J. Respir. Crit. Care Med.,2017

5. Molecular targets for modulating lung inflammation and injury;Sadikot;Curr. Drug Targets,2004

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. R406 reduces lipopolysaccharide-induced neutrophil activation;Cellular Immunology;2024-09

2. Spleen tyrosine kinase inhibitor R406 has both antiviral and anti‐inflammatory effects on severe influenza A infection;Journal of Medical Virology;2024-05

3. The Role of Oxidative Stress in Tumorigenesis and Progression;Cells;2024-03-02

4. EGR-1 Contributes to Pulmonary Edema by Regulating the Epithelial Sodium Channel in Lipopolysaccharide-Induced Acute Lung Injury;Immunological Investigations;2023-09-21

5. Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases;Immunity, Inflammation and Disease;2023-07